Global Human Microbiome Market: Industry Analysis and Forecast (2019-2027), By Product, Applications, Diseases and Region.

Global Human Microbiome Market was valued US$ XX Mn in 2019 and is expected to reach US$ 1246.29 Mn by 2027, at a CAGR of around XX % during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report The human microbiome is the collection of all microbiota that resides on or within any human tissues and bio fluids, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary, and gastrointestinal tracts. It includes; bacteria, archaea, fungi, protists, and viruses. The correlation of most microbes with the human body varies from being commensal and mutualistic to neutral and harmful. Human microbiome-based therapies are existing in the form of foods, prebiotics, diagnostic devices, probiotics, medical foods, drugs, and supplements. Technological advancements in metagenomics and next-generation sequencing have made microbiome-based testing easier and inexpensive. The rising incidence of lifestyle-related diseases, globally, is a strong driver of the human microbiome market, as therapeutics may provide an alternative route to tackle significant healthcare challenges, such as obesity, autoimmune disorders, and antibiotic resistance, genomic disorders, Gastrointestinal diseases, cancer, Crohn’s syndrome, and bowel syndrome. However, the strict government guidelines are intended to hamper the Human Microbiome Market to an extent. Lack of awareness, technological expertise, and skilled professionals pose significant limitations, ultimately restricting the growth of the Human Microbiome Market. According to the Application segment, the therapeutics segment held the largest share of the market. The therapeutic segment is also expected to grow at a balanced rate during the forecast period, owing to the increase in digestive problems, increase in the drug-related side effects. Region-wise, North America is likely to dominate the Human Microbiome Market in the forecast period, because of, Increase in the number of ongoing clinical trials and early adoption of recently developed technologies On the other hand, the Europe market is booming as a result of growing initiatives by central government in research and development along with establishments of startups. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Human Microbiome Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Global Human Microbiome Market.

Scope of Global Human Microbiome Market: Inquire before buying

Global Human Microbiome Market, By Product

• Probiotics • Prebiotics • Medical Foods • Supplements • Others

Global Human Microbiome Market, By Applications

• Therapeutics • Diagnostics

Global Human Microbiome Market, By Diseases

• Obesity • Diabetes • Autoimmune Disorder • Metabolic & Gastrointestinal Disorders • Cancer • Other Diseases

Global Human Microbiome Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Key Players Operating in Global Human Microbiome Market

• Enterome Bioscience • E.I. Du Pont De Nemours and Company • Merck & Co., Inc. • Metabiomics Corporation • Yakult Honsha Co., Ltd. • Microbiome Therapeutics, LLC • Osel, Inc. • Second Genome, Inc. • Vithera Pharmaceuticals • Vedanta Biosciences, Inc. • Seres Therapeutics • Synthetic Biologics Inc. • Synlogic Inc. • 4D pharma • Evelo Biosciences • OptiBiotix Health • Ferring Pharmaceuticals • BiomX • Kaleido • YSOPIA Bioscience • FlightPath • Finch Therapeutics • Quantbiome • Viome, Inc. • DayTwo

Global Human Microbiome Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Human Microbiome Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Human Microbiome Market Analysis and Forecast 6.1. Global Human Microbiome Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Human Microbiome Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Human Microbiome Market Value Share Analysis, by Product 7.4. Global Human Microbiome Market Size (US$ Mn) Forecast, by Product 7.5. Global Human Microbiome Market Analysis, by Product 7.6. Global Human Microbiome Market Attractiveness Analysis, by Product 8. Global Human Microbiome Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Human Microbiome Market Value Share Analysis, by Application 8.4. Global Human Microbiome Market Size (US$ Mn) Forecast, by Application 8.5. Global Human Microbiome Market Analysis, by Application 8.6. Global Human Microbiome Market Attractiveness Analysis, by Application 9. Global Human Microbiome Market Analysis and Forecast, by Diseases 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Human Microbiome Market Value Share Analysis, by Diseases 9.4. Global Human Microbiome Market Size (US$ Mn) Forecast, by Diseases 9.5. Global Human Microbiome Market Analysis, by Diseases 9.6. Global Human Microbiome Market Attractiveness Analysis, by Diseases 10. Global Human Microbiome Market Analysis, by Region 10.1. Global Human Microbiome Market Value Share Analysis, by Region 10.2. Global Human Microbiome Market Size (US$ Mn) Forecast, by Region 10.3. Global Human Microbiome Market Attractiveness Analysis, by Region 11. North America Human Microbiome Market Analysis 11.1. Key Findings 11.2. North America Human Microbiome Market Overview 11.3. North America Human Microbiome Market Value Share Analysis, by Product 11.4. North America Human Microbiome Market Forecast, by Product 11.4.1. Probiotics 11.4.2. Prebiotics 11.4.3. Medical Foods 11.4.4. Supplements 11.4.5. Others 11.5. North America Human Microbiome Market Value Share Analysis, by Application 11.6. North America Human Microbiome Market Forecast, by Application 11.6.1. Therapeutics 11.6.2. Diagnostics 11.7. North America Human Microbiome Market Value Share Analysis, by Diseases 11.8. North America Human Microbiome Market Forecast, by Diseases 11.8.1. Obesity 11.8.2. Diabetes 11.8.3. Autoimmune Disorder 11.8.4. Metabolic & Gastrointestinal Disorders 11.8.5. Cancer 11.8.6. Other Diseases 11.9. North America Human Microbiome Market Value Share Analysis, by Country 11.10. North America Human Microbiome Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Human Microbiome Market Analysis, by Country 11.12. U.S. Human Microbiome Market Forecast, by Product 11.12.1. Probiotics 11.12.2. Prebiotics 11.12.3. Medical Foods 11.12.4. Supplements 11.12.5. Others 11.13. U.S. Human Microbiome Market Forecast, by Application 11.13.1. Therapeutics 11.13.2. Diagnostics 11.14. U.S. Human Microbiome Market Forecast, by Diseases 11.14.1. Obesity 11.14.2. Diabetes 11.14.3. Autoimmune Disorder 11.14.4. Metabolic & Gastrointestinal Disorders 11.14.5. Cancer 11.14.6. Other Diseases 11.15. Canada Human Microbiome Market Forecast, by Product 11.15.1. Probiotics 11.15.2. Prebiotics 11.15.3. Medical Foods 11.15.4. Supplements 11.15.5. Others 11.16. Steel Canada Human Microbiome Market Forecast, by Application 11.16.1. Therapeutics 11.16.2. Diagnostics 11.17. Canada Human Microbiome Market Forecast, by Diseases 11.17.1. Obesity 11.17.2. Diabetes 11.17.3. Autoimmune Disorder 11.17.4. Metabolic & Gastrointestinal Disorders 11.17.5. Cancer 11.17.6. Other Diseases 11.18. North America Human Microbiome Market Attractiveness Analysis 11.18.1. By Product 11.18.2. By Application 11.18.3. By Diseases 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Human Microbiome Market Analysis 12.1. Key Findings 12.2. Europe Human Microbiome Market Overview 12.3. Europe Human Microbiome Market Value Share Analysis, by Product 12.4. Europe Human Microbiome Market Forecast, by Product 12.4.1. Probiotics 12.4.2. Prebiotics 12.4.3. Medical Foods 12.4.4. Supplements 12.4.5. Others 12.5. Europe Human Microbiome Market Value Share Analysis, by Application 12.6. Europe Human Microbiome Market Forecast, by Application 12.6.1. Therapeutics 12.6.2. Diagnostics 12.7. Europe Human Microbiome Market Value Share Analysis, by Diseases 12.8. Europe Human Microbiome Market Forecast, by Diseases 12.8.1. Obesity 12.8.2. Diabetes 12.8.3. Autoimmune Disorder 12.8.4. Metabolic & Gastrointestinal Disorders 12.8.5. Cancer 12.8.6. Other Diseases 12.9. Europe Human Microbiome Market Value Share Analysis, by Country 12.10. Europe Human Microbiome Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Human Microbiome Market Analysis, by Country 12.12. Germany Human Microbiome Market Forecast, by Product 12.12.1. Probiotics 12.12.2. Prebiotics 12.12.3. Medical Foods 12.12.4. Supplements 12.12.5. Others 12.13. Germany Human Microbiome Market Forecast, by Application 12.13.1. Therapeutics 12.13.2. Diagnostics 12.14. Germany Human Microbiome Market Forecast, by Diseases 12.14.1. Obesity 12.14.2. Diabetes 12.14.3. Autoimmune Disorder 12.14.4. Metabolic & Gastrointestinal Disorders 12.14.5. Cancer 12.14.6. Other Diseases 12.15. U.K. Human Microbiome Market Forecast, by Product 12.15.1. Probiotics 12.15.2. Prebiotics 12.15.3. Medical Foods 12.15.4. Supplements 12.15.5. Others 12.16. U.K. Human Microbiome Market Forecast, by Application 12.16.1. Therapeutics 12.16.2. Diagnostics 12.17. U.K. Human Microbiome Market Forecast, by Diseases 12.17.1. Obesity 12.17.2. Diabetes 12.17.3. Autoimmune Disorder 12.17.4. Metabolic & Gastrointestinal Disorders 12.17.5. Cancer 12.17.6. Other Diseases 12.18. France Human Microbiome Market Forecast, by Product 12.18.1. Probiotics 12.18.2. Prebiotics 12.18.3. Medical Foods 12.18.4. Supplements 12.18.5. Others 12.19. France Human Microbiome Market Forecast, by Application 12.19.1. Therapeutics 12.19.2. Diagnostics 12.20. France Human Microbiome Market Forecast, by Diseases 12.20.1. Obesity 12.20.2. Diabetes 12.20.3. Autoimmune Disorder 12.20.4. Metabolic & Gastrointestinal Disorders 12.20.5. Cancer 12.20.6. Other Diseases 12.21. Italy Human Microbiome Market Forecast, by Product 12.21.1. Probiotics 12.21.2. Prebiotics 12.21.3. Medical Foods 12.21.4. Supplements 12.21.5. Others 12.22. Italy Human Microbiome Market Forecast, by Application 12.22.1. Therapeutics 12.22.2. Diagnostics 12.23. Italy Human Microbiome Market Forecast, by Diseases 12.23.1. Obesity 12.23.2. Diabetes 12.23.3. Autoimmune Disorder 12.23.4. Metabolic & Gastrointestinal Disorders 12.23.5. Cancer 12.23.6. Other Diseases 12.24. Spain Human Microbiome Market Forecast, by Product 12.24.1. Probiotics 12.24.2. Prebiotics 12.24.3. Medical Foods 12.24.4. Supplements 12.24.5. Others 12.25. Spain Human Microbiome Market Forecast, by Application 12.25.1. Therapeutics 12.25.2. Diagnostics 12.26. Spain Human Microbiome Market Forecast, by Diseases 12.26.1. Obesity 12.26.2. Diabetes 12.26.3. Autoimmune Disorder 12.26.4. Metabolic & Gastrointestinal Disorders 12.26.5. Cancer 12.26.6. Other Diseases 12.27. Rest of Europe Human Microbiome Market Forecast, by Product 12.27.1. Probiotics 12.27.2. Prebiotics 12.27.3. Medical Foods 12.27.4. Supplements 12.27.5. Others 12.28. Rest of Europe Human Microbiome Market Forecast, by Application 12.28.1. Therapeutics 12.28.2. Diagnostics 12.29. Rest Of Europe Human Microbiome Market Forecast, by Diseases 12.29.1. Obesity 12.29.2. Diabetes 12.29.3. Autoimmune Disorder 12.29.4. Metabolic & Gastrointestinal Disorders 12.29.5. Cancer 12.29.6. Other Diseases 12.30. Europe Human Microbiome Market Attractiveness Analysis 12.30.1. By Product 12.30.2. By Application 12.30.3. By Diseases 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Human Microbiome Market Analysis 13.1. Key Findings 13.2. Asia Pacific Human Microbiome Market Overview 13.3. Asia Pacific Human Microbiome Market Value Share Analysis, by Product 13.4. Asia Pacific Human Microbiome Market Forecast, by Product 13.4.1. Probiotics 13.4.2. Prebiotics 13.4.3. Medical Foods 13.4.4. Supplements 13.4.5. Others 13.5. Asia Pacific Human Microbiome Market Value Share Analysis, by Application 13.6. Asia Pacific Human Microbiome Market Forecast, by Application 13.6.1. Therapeutics 13.6.2. Diagnostics 13.7. Asia Pacific Human Microbiome Market Value Share Analysis, by Diseases 13.8. Asia Pacific Human Microbiome Market Forecast, by Diseases 13.8.1. Obesity 13.8.2. Diabetes 13.8.3. Autoimmune Disorder 13.8.4. Metabolic & Gastrointestinal Disorders 13.8.5. Cancer 13.8.6. Other Diseases 13.9. Asia Pacific Human Microbiome Market Value Share Analysis, by Country 13.10. Asia Pacific Human Microbiome Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Human Microbiome Market Analysis, by Country 13.12. China Human Microbiome Market Forecast, by Product 13.12.1. Probiotics 13.12.2. Prebiotics 13.12.3. Medical Foods 13.12.4. Supplements 13.12.5. Others 13.13. China Human Microbiome Market Forecast, by Application 13.13.1. Therapeutics 13.13.2. Diagnostics 13.14. China Human Microbiome Market Forecast, by Diseases 13.14.1. Obesity 13.14.2. Diabetes 13.14.3. Autoimmune Disorder 13.14.4. Metabolic & Gastrointestinal Disorders 13.14.5. Cancer 13.14.6. Other Diseases 13.15. India Human Microbiome Market Forecast, by Product 13.15.1. Probiotics 13.15.2. Prebiotics 13.15.3. Medical Foods 13.15.4. Supplements 13.15.5. Others 13.16. India Human Microbiome Market Forecast, by Application 13.16.1. Therapeutics 13.16.2. Diagnostics 13.17. India Human Microbiome Market Forecast, by Diseases 13.17.1. Obesity 13.17.2. Diabetes 13.17.3. Autoimmune Disorder 13.17.4. Metabolic & Gastrointestinal Disorders 13.17.5. Cancer 13.17.6. Other Diseases 13.18. Japan Human Microbiome Market Forecast, by Product 13.18.1. Probiotics 13.18.2. Prebiotics 13.18.3. Medical Foods 13.18.4. Supplements 13.18.5. Others 13.19. Japan Human Microbiome Market Forecast, by Application 13.19.1. Therapeutics 13.19.2. Diagnostics 13.20. Japan Human Microbiome Market Forecast, by Diseases 13.20.1. Obesity 13.20.2. Diabetes 13.20.3. Autoimmune Disorder 13.20.4. Metabolic & Gastrointestinal Disorders 13.20.5. Cancer 13.20.6. Other Diseases 13.21. ASEAN Human Microbiome Market Forecast, by Product 13.21.1. Probiotics 13.21.2. Prebiotics 13.21.3. Medical Foods 13.21.4. Supplements 13.21.5. Others 13.22. ASEAN Human Microbiome Market Forecast, by Application 13.22.1. Therapeutics 13.22.2. Diagnostics 13.23. ASEAN Human Microbiome Market Forecast, by Diseases 13.23.1. Obesity 13.23.2. Diabetes 13.23.3. Autoimmune Disorder 13.23.4. Metabolic & Gastrointestinal Disorders 13.23.5. Cancer 13.23.6. Other Diseases 13.24. Rest of Asia Pacific Human Microbiome Market Forecast, by Product 13.24.1. Probiotics 13.24.2. Prebiotics 13.24.3. Medical Foods 13.24.4. Supplements 13.24.5. Others 13.25. Rest of Asia Pacific Human Microbiome Market Forecast, by Application 13.25.1. Therapeutics 13.25.2. Diagnostics 13.26. Rest of Asia Pacific Human Microbiome Market Forecast, by Diseases 13.26.1. Obesity 13.26.2. Diabetes 13.26.3. Autoimmune Disorder 13.26.4. Metabolic & Gastrointestinal Disorders 13.26.5. Cancer 13.26.6. Other Diseases 13.27. Asia Pacific Human Microbiome Market Attractiveness Analysis 13.27.1. By Product 13.27.2. By Application 13.27.3. By Diseases 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Human Microbiome Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Human Microbiome Market Overview 14.3. Middle East & Africa Human Microbiome Market Value Share Analysis, by Product 14.4. Middle East & Africa Human Microbiome Market Forecast, by Product 14.4.1. Probiotics 14.4.2. Prebiotics 14.4.3. Medical Foods 14.4.4. Supplements 14.4.5. Others 14.5. Middle East & Africa Human Microbiome Market Value Share Analysis, by Application 14.6. Middle East & Africa Human Microbiome Market Forecast, by Application 14.6.1. Therapeutics 14.6.2. Diagnostics 14.7. Middle East & Africa Human Microbiome Market Value Share Analysis, by Diseases 14.8. Middle East & Africa Human Microbiome Market Forecast, by Diseases 14.8.1. Obesity 14.8.2. Diabetes 14.8.3. Autoimmune Disorder 14.8.4. Metabolic & Gastrointestinal Disorders 14.8.5. Cancer 14.8.6. Other Diseases 14.9. Middle East & Africa Human Microbiome Market Value Share Analysis, by Country 14.10. Middle East & Africa Human Microbiome Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Human Microbiome Market Analysis, by Country 14.12. GCC Human Microbiome Market Forecast, by Product 14.12.1. Probiotics 14.12.2. Prebiotics 14.12.3. Medical Foods 14.12.4. Supplements 14.12.5. Others 14.13. GCC Human Microbiome Market Forecast, by Application 14.13.1. Therapeutics 14.13.2. Diagnostics 14.14. GCC Human Microbiome Market Forecast, by Diseases 14.14.1. Obesity 14.14.2. Diabetes 14.14.3. Autoimmune Disorder 14.14.4. Metabolic & Gastrointestinal Disorders 14.14.5. Cancer 14.14.6. Other Diseases 14.15. South Africa Human Microbiome Market Forecast, by Product 14.15.1. Probiotics 14.15.2. Prebiotics 14.15.3. Medical Foods 14.15.4. Supplements 14.15.5. Others 14.16. South Africa Human Microbiome Market Forecast, by Application 14.16.1. Therapeutics 14.16.2. Diagnostics 14.17. South Africa Human Microbiome Market Forecast, by Diseases 14.17.1. Obesity 14.17.2. Diabetes 14.17.3. Autoimmune Disorder 14.17.4. Metabolic & Gastrointestinal Disorders 14.17.5. Cancer 14.17.6. Other Diseases 14.18. Rest of Middle East & Africa Human Microbiome Market Forecast, by Product 14.18.1. Probiotics 14.18.2. Prebiotics 14.18.3. Medical Foods 14.18.4. Supplements 14.18.5. Others 14.19. Rest of Middle East & Africa Human Microbiome Market Forecast, by Application 14.19.1. Therapeutics 14.19.2. Diagnostics 14.20. Rest of Middle East & Africa Human Microbiome Market Forecast, by Diseases 14.20.1. Obesity 14.20.2. Diabetes 14.20.3. Autoimmune Disorder 14.20.4. Metabolic & Gastrointestinal Disorders 14.20.5. Cancer 14.20.6. Other Diseases 14.21. Middle East & Africa Human Microbiome Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By Application 14.21.3. By Diseases 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Human Microbiome Market Analysis 15.1. Key Findings 15.2. South America Human Microbiome Market Overview 15.3. South America Human Microbiome Market Value Share Analysis, by Product 15.4. South America Human Microbiome Market Forecast, by Product 15.4.1. Probiotics 15.4.2. Prebiotics 15.4.3. Medical Foods 15.4.4. Supplements 15.4.5. Others 15.5. South America Human Microbiome Market Value Share Analysis, by Application 15.6. South America Human Microbiome Market Forecast, by Application 15.6.1. Therapeutics 15.6.2. Diagnostics 15.7. South America Human Microbiome Market Value Share Analysis, by Diseases 15.8. South America Human Microbiome Market Forecast, by Diseases 15.8.1. Obesity 15.8.2. Diabetes 15.8.3. Autoimmune Disorder 15.8.4. Metabolic & Gastrointestinal Disorders 15.8.5. Cancer 15.8.6. Other Diseases 15.9. South America Human Microbiome Market Value Share Analysis, by Country 15.10. South America Human Microbiome Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Human Microbiome Market Analysis, by Country 15.12. Brazil Human Microbiome Market Forecast, by Product 15.12.1. Probiotics 15.12.2. Prebiotics 15.12.3. Medical Foods 15.12.4. Supplements 15.12.5. Others 15.13. Brazil Human Microbiome Market Forecast, by Application 15.13.1. Therapeutics 15.13.2. Diagnostics 15.14. Brazil Human Microbiome Market Forecast, by Diseases 15.14.1. Obesity 15.14.2. Diabetes 15.14.3. Autoimmune Disorder 15.14.4. Metabolic & Gastrointestinal Disorders 15.14.5. Cancer 15.14.6. Other Diseases 15.15. Mexico Human Microbiome Market Forecast, by Product 15.15.1. Probiotics 15.15.2. Prebiotics 15.15.3. Medical Foods 15.15.4. Supplements 15.15.5. Others 15.16. Mexico Human Microbiome Market Forecast, by Application 15.16.1. Therapeutics 15.16.2. Diagnostics 15.17. Mexico Human Microbiome Market Forecast, by Diseases 15.17.1. Obesity 15.17.2. Diabetes 15.17.3. Autoimmune Disorder 15.17.4. Metabolic & Gastrointestinal Disorders 15.17.5. Cancer 15.17.6. Other Diseases 15.18. Rest of South America Human Microbiome Market Forecast, by Product 15.18.1. Probiotics 15.18.2. Prebiotics 15.18.3. Medical Foods 15.18.4. Supplements 15.18.5. Others 15.19. Rest of South America Human Microbiome Market Forecast, by Application 15.19.1. Therapeutics 15.19.2. Diagnostics 15.20. Rest of South America Human Microbiome Market Forecast, by Diseases 15.20.1. Obesity 15.20.2. Diabetes 15.20.3. Autoimmune Disorder 15.20.4. Metabolic & Gastrointestinal Disorders 15.20.5. Cancer 15.20.6. Other Diseases 15.21. South America Human Microbiome Market Attractiveness Analysis 15.21.1. By Product 15.21.2. By Application 15.21.3. By Diseases 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Enterome Bioscience 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Developing Footprint 16.3.2. E.I. Du Pont De Nemours and Company 16.3.3. Merck & Co., Inc. 16.3.4. Metabiomics Corporation 16.3.5. Yakult Honsha Co., Ltd. 16.3.6. Microbiome Therapeutics, LLC 16.3.7. Osel, Inc. 16.3.8. Second Genome, Inc. 16.3.9. Vithera Pharmaceuticals 16.3.10. Vedanta Biosciences, Inc. 16.3.11. Seres Therapeutics 16.3.12. Synthetic Biologics Inc. 16.3.13. Synlogic Inc. 16.3.14. 4D pharma 16.3.15. Evelo Biosciences 16.3.16. OptiBiotix Health 16.3.17. Ferring Pharmaceuticals 16.3.18. BiomX 16.3.19. Kaleido 16.3.20. YSOPIA Bioscience 16.3.21. FlightPath 16.3.22. Finch Therapeutics 16.3.23. Quantbiome 16.3.24. Viome, Inc. 16.3.25. DayTwo 17. Primary Key Insights

About This Report

Report ID 33879
Category Life Science
Published Date Aug 2019
Updated Date
Contact Us